365 related articles for article (PubMed ID: 32376258)
1. Mu-opioid and CB1 cannabinoid receptors of the dorsal periaqueductal gray interplay in the regulation of fear response, but not antinociception.
Godoi MM; Junior HZ; da Cunha JM; Zanoveli JM
Pharmacol Biochem Behav; 2020 Jul; 194():172938. PubMed ID: 32376258
[TBL] [Abstract][Full Text] [Related]
2. Panicolytic-like action of bradykinin in the dorsal periaqueductal gray through μ-opioid and B2-kinin receptors.
Sestile CC; Maraschin JC; Gama VS; Zangrossi H; Graeff FG; Audi EA
Neuropharmacology; 2017 Sep; 123():80-87. PubMed ID: 28554847
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological evidence for the mediation of the panicolytic effect of fluoxetine by dorsal periaqueductal gray matter μ-opioid receptors.
Roncon CM; Almada RC; Maraschin JC; Audi EA; Zangrossi H; Graeff FG; Coimbra NC
Neuropharmacology; 2015 Dec; 99():620-6. PubMed ID: 26320545
[TBL] [Abstract][Full Text] [Related]
4. Positive allosteric modulation of the cannabinoid type-1 receptor (CB1R) in periaqueductal gray (PAG) antagonizes anti-nociceptive and cellular effects of a mu-opioid receptor agonist in morphine-withdrawn rats.
Datta U; Kelley LK; Middleton JW; Gilpin NW
Psychopharmacology (Berl); 2020 Dec; 237(12):3729-3739. PubMed ID: 32857187
[TBL] [Abstract][Full Text] [Related]
5. Defensive-like behaviors and antinociception induced by NMDA injection into the periaqueductal gray of mice depend on nitric oxide synthesis.
Miguel TT; Nunes-de-Souza RL
Brain Res; 2006 Mar; 1076(1):42-8. PubMed ID: 16476419
[TBL] [Abstract][Full Text] [Related]
6. The unconditioned fear produced by morphine withdrawal is regulated by mu- and kappa-opioid receptors in the midbrain tectum.
De Ross J; Avila MA; Ruggiero RN; Nobre MJ; Brandão ML; Castilho VM
Behav Brain Res; 2009 Dec; 204(1):140-6. PubMed ID: 19520121
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of the excitatory action of NMDA in ventrolateral periaqueductal gray by the mu-opioid receptor agonist, DAMGO.
Kow LM; Commons KG; Ogawa S; Pfaff DW
Brain Res; 2002 May; 935(1-2):87-102. PubMed ID: 12062477
[TBL] [Abstract][Full Text] [Related]
8. Interaction between μ-opioid and 5-HT1A receptors in the regulation of panic-related defensive responses in the rat dorsal periaqueductal grey.
Rangel MP; Zangrossi H; Roncon CM; Graeff FG; Audi EA
J Psychopharmacol; 2014 Dec; 28(12):1155-60. PubMed ID: 25315826
[TBL] [Abstract][Full Text] [Related]
9. The mu-opioid receptor agonist morphine, but not agonists at delta- or kappa-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors.
da Fonseca Pacheco D; Klein A; de Castro Perez A; da Fonseca Pacheco CM; de Francischi JN; Duarte ID
Br J Pharmacol; 2008 Jul; 154(5):1143-9. PubMed ID: 18469844
[TBL] [Abstract][Full Text] [Related]
10. Medial prefrontal cortex diclofenac-induced antinociception is mediated through GPR55, cannabinoid CB1, and mu-opioid receptors of this area and periaqueductal gray.
Tamaddonfard E; Erfanparast A; Salighedar R; Tamaddonfard S
Naunyn Schmiedebergs Arch Pharmacol; 2020 Mar; 393(3):371-379. PubMed ID: 31641818
[TBL] [Abstract][Full Text] [Related]
11. Antinociception produced by mu opioid receptor activation in the amygdala is partly dependent on activation of mu opioid and neurotensin receptors in the ventral periaqueductal gray.
Tershner SA; Helmstetter FJ
Brain Res; 2000 May; 865(1):17-26. PubMed ID: 10814729
[TBL] [Abstract][Full Text] [Related]
12. L-allylglycine dissociates the neural substrates of fear in the periaqueductal gray of rats.
Cunha JM; Zanoveli JM; Ledvinka-Filho E; Brandão ML
Brain Res Bull; 2010 Mar; 81(4-5):416-23. PubMed ID: 19800953
[TBL] [Abstract][Full Text] [Related]
13. Functional interaction between orexin-1 and CB1 receptors in the periaqueductal gray matter during antinociception induced by chemical stimulation of the lateral hypothalamus in rats.
Esmaeili MH; Reisi Z; Ezzatpanah S; Haghparast A
Eur J Pain; 2016 Nov; 20(10):1753-1762. PubMed ID: 27301294
[TBL] [Abstract][Full Text] [Related]
14. Role of benzodiazepine and serotonergic mechanisms in conditioned freezing and antinociception using electrical stimulation of the dorsal periaqueductal gray as unconditioned stimulus in rats.
Castilho VM; Macedo CE; Brandão ML
Psychopharmacology (Berl); 2002 Dec; 165(1):77-85. PubMed ID: 12474121
[TBL] [Abstract][Full Text] [Related]
15. Endogenous opioid peptides acting at mu-opioid receptors in the dorsal horn contribute to midbrain modulation of spinal nociceptive neurons.
Budai D; Fields HL
J Neurophysiol; 1998 Feb; 79(2):677-87. PubMed ID: 9463431
[TBL] [Abstract][Full Text] [Related]
16. μ-Opioid and 5-HT1A receptors in the dorsomedial hypothalamus interact for the regulation of panic-related defensive responses.
Roncon CM; Yamashita PSM; Frias AT; Audi EA; Graeff FG; Coimbra NC; Zangrossi H
J Psychopharmacol; 2017 Jun; 31(6):715-721. PubMed ID: 28583050
[TBL] [Abstract][Full Text] [Related]
17. Participation of dorsal periaqueductal gray 5-HT1A receptors in the panicolytic-like effect of the κ-opioid receptor antagonist Nor-BNI.
Maraschin JC; Almeida CB; Rangel MP; Roncon CM; Sestile CC; Zangrossi H; Graeff FG; Audi EA
Behav Brain Res; 2017 Jun; 327():75-82. PubMed ID: 28347824
[TBL] [Abstract][Full Text] [Related]
18. Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.
Smith PA; Selley DE; Sim-Selley LJ; Welch SP
Eur J Pharmacol; 2007 Oct; 571(2-3):129-37. PubMed ID: 17603035
[TBL] [Abstract][Full Text] [Related]
19. Repeated morphine treatment alters cannabinoid modulation of GABAergic synaptic transmission within the rat periaqueductal grey.
Wilson-Poe AR; Lau BK; Vaughan CW
Br J Pharmacol; 2015 Jan; 172(2):681-90. PubMed ID: 24916363
[TBL] [Abstract][Full Text] [Related]
20. µ- and κ-Opioid receptor activation in the dorsal periaqueductal grey matter differentially modulates panic-like behaviours induced by electrical and chemical stimulation of the inferior colliculus.
Twardowschy A; Coimbra NC
Brain Res; 2015 Feb; 1597():168-79. PubMed ID: 25485771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
